Halozyme Therapeutics, Inc.
HALO
$71.48
$0.751.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 123.09% | -79.65% | 28.05% | -26.71% | 25.47% |
| Total Receivables | 3.79% | 27.52% | 9.39% | 3.85% | -1.24% |
| Inventory | -11.90% | -5.02% | 2.36% | 10.09% | 16.22% |
| Prepaid Expenses | 9.16% | -31.93% | 23.88% | 71.80% | 14.55% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 21.55% | -37.90% | 18.36% | -11.04% | 16.28% |
|
|
|||||
| Total Current Assets | 21.55% | -37.90% | 18.36% | -11.04% | 16.28% |
| Net Property, Plant & Equipment | 0.11% | 15.01% | -0.14% | -1.78% | -2.96% |
| Long-term Investments | 0.34% | 39.23% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.34% | 39.23% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -3.01% | 181.59% | -4.85% | -4.62% | -4.42% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -5.30% | 0.82% | -27.27% | 25.95% | -28.01% |
| Total Assets | 5.84% | 13.69% | 8.15% | -6.49% | 6.45% |
|
|
|||||
| Total Accounts Payable | -32.54% | 36.06% | -17.82% | -6.89% | 95.86% |
| Total Accrued Expenses | -3.14% | 30.34% | -3.81% | -11.29% | 1.13% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,751.05% | -98.41% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 105.10% | -78.85% | 523.48% | -10.70% | 8.11% |
|
|
|||||
| Total Current Liabilities | 105.10% | -78.85% | 523.48% | -10.70% | 8.11% |
| Long-Term Debt | -9.65% | 167.80% | -46.98% | 0.11% | 0.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -17.11% | -3.00% | -1.43% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.34% | 157.14% | 6.39% | 80.42% | -50.61% |
| Total Liabilities | -0.95% | 44.21% | -0.22% | 0.40% | 0.86% |
|
|
|||||
| Common Stock & APIC | 126.93% | -49.56% | 20,261.86% | -98.47% | 6,175.61% |
| Retained Earnings | 273.88% | -89.09% | 39.09% | -24.46% | 32.82% |
| Treasury Stock & Other | 29.79% | 18.72% | 21.64% | -732.20% | -189.14% |
| Total Common Equity | 349.94% | -90.31% | 51.44% | -31.00% | 32.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 349.94% | -90.31% | 51.44% | -31.00% | 32.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 349.94% | -90.31% | 51.44% | -31.00% | 32.56% |
|
|
|||||